Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis
Clinical trial NCT00213564 · COMPLETED
Trial details
- NCT number
- NCT00213564
- Sponsor
- University Hospital, Rouen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2003-04-01
- Primary completion
- 2004-05-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.